Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 135 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Low-Risk Prostate Cancer Clear all

Conditions: Prostate Cancer
Interventions: Blood Drawing; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Low Risk Prostate Cancer
Interventions: assessments; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 541 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2027
U.S. locations: 3
States / cities: Harrison, New York • New York, New York

Conditions: Prostate Cancer, High-Risk Localized Prostate Cancer, Locally Advanced Prostate Cancer, Low-Risk Prostate Cancer, Intermediate Risk Prostate Cancer
Interventions: PSMA PET, MRI, 18F-DCFPyL; Device · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Prostate Cancer, Cancer of the Prostate, Prostate Neoplasm
Interventions: CyberKnife Radiosurgery; Radiation
Lead sponsor: Community Cancer Center, Normal, Illinois; Other
Eligibility: 21 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Normal, Illinois

Conditions: Prostate Cancer, Kidney Cancer
Interventions: High intensity approach, Low intensity approach; Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland • Chambersburg, Pennsylvania

Conditions: Prostate Cancer
Interventions: 70 Gy/CGE, 72.5 Gy/CGE; Radiation
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older · Male only
Enrollment: 361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Prostate Cancer
Interventions: Radiation Therapy; Radiation
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 90 Years · Male only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: Decipher® Testing; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 3
States / cities: Bay Pines, Florida • Tampa, Florida

Conditions: Prostate Cancer
Interventions: Curcumin, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 40 Years to 89 Years · Male only
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Metastatic Castration Resistant Prostate Cancer
Interventions: LAVA-1207, LAVA-1207 plus Pembrolizumab; Biological
Lead sponsor: Lava Therapeutics; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 6
States / cities: San Francisco, California • Minneapolis, Minnesota • St Louis, Missouri + 3 more

Conditions: Prostate Cancer
Interventions: Amount of Pneumoperitoneum Pressure applied during RARP; Procedure
Lead sponsor: Metro Health, Michigan; Other
Eligibility: 40 Years and older · Male only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Prostate Cancer
Interventions: Apalutamide, Abiraterone Acetate, Prednisone, GnRH agonist/antagonist; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 11
States / cities: Chicago, Illinois • Evanston, Illinois • Boston, Massachusetts + 8 more

Conditions: Prostate Adenocarcinoma
Interventions: Proton Therapy, IMRT; Radiation
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Male only
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2026
U.S. locations: 2
States / cities: Bethesda, Maryland • Philadelphia, Pennsylvania

Conditions: Prostate Cancer
Interventions: Unilateral Nerve-Sparing Cryoablation of the Prostate, Precise Cryoablation System with IceRod Needles; Procedure · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 40 Years to 69 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Prostate Cancer
Interventions: Proton Radiation Hypofractionation, Proton Radiation Standard Fractionation; Radiation
Lead sponsor: Proton Collaborative Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 5
States / cities: Phoenix, Arizona • Warrenville, Illinois • Baltimore, Maryland + 2 more

Conditions: Nonmalignant Neoplasm, Prostate Cancer
Interventions: dutasteride; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Prostate Cancer
Interventions: Noni extract; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 55 Years and older · Male only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Prostatic Neoplasms
Interventions: CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide; Drug · Other
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Erectile Dysfunction, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8
Interventions: Nerve-Sparing Prostatectomy, Medical Device Usage and Evaluation, Duplex Ultrasound, Survey Administration, Sham Intervention; Procedure · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer
Interventions: stereotactic body radiation therapy, four fraction split-course SBRT; Radiation
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: Charlottesville, Virginia • Richmond, Virginia

Conditions: Prostate Cancer
Interventions: Vitamin D3, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years to 90 Years · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Prostate Cancer, Localized Prostate Carcinoma
Interventions: Microboost SBRT, Whole gland de-escalation 30 Gy, Whole gland de-escalation 35 Gy; Radiation
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Neoplasms, Prostate
Interventions: Dutasteride, Matching placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years to 80 Years · Male only
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 58
States / cities: Little Rock, Arkansas • Beverly Hills, California • Laguna Hills, California + 54 more

Conditions: Prostate Cancer
Interventions: Fish Oil, Vitamin E supplement, Western Diet, Low-Fat Diet, Medical Examination, Dietary Interview, Blood Draw, Radical Prostatectomy; Dietary Supplement · Other · Procedure
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 40 Years to 75 Years · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2018
U.S. locations: 2
States / cities: Los Angeles, California

Search by objective public record fields.

Circulating Tumor Cells in Prostate Cancer Patients

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

PSMA PET/MRI for Predicting and Detecting Prostate Cancer

A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Validation Study on the Impact of Decipher® Testing - VANDAAM Study

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

The Impact of Low Pressure Pneumo in RARP

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

LiSWT for Nerve Sparing Radical Prostatectomy ED

Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer

Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Low-Fat Fish Oil Diet for Prostate Cancer Prevention